Alphabet Inc.
Alphabet Inc. reported 28 US-listed holdings worth $99.08 billion in its 13F for the quarter ended 30 June 2026, filed 7 August 2026. Its largest: Space Exploration Techn Corp. Class A Com STK (95.0%), Planet Labs PBC (1.2%) and Ast Spacemobile Inc. (0.8%). Against the quarter before, it opened 3 positions, added to 0, trimmed 4 and sold out of 1.
Reported holdings$99.08B+2367.4% on Q1 2026
Positions28+2 on Q1 2026
The largest ten99.5%of its reported holdings
Latest 13FQ2 2026filed 7 August 2026
OpenedHeldTrimmed
The 14 largest of its 28 positions, each sized by its share of the reported holdings, coloured by the change in shares against Q1 2026.
What the fund reported holding at each quarter's end; hover a bar for the number of positions
What it did on the quarter
Opened 3Held 21Trimmed 4Sold out 1
Its positions against its 13F for the quarter to 31 March 2026; a change under 0.1% of a position counts as held
Opened 3
- Space Exploration Techn Corp. Class A Com STK SPCX$94.18 billion
- Parabilis Medicines Inc. Com PBLS$134.6 million
- Fervo Energy Co. Class A Com FRVO$51.5 million
Trimmed 4
- Revolution Medicines, Inc. RVMD-345,906 shares · -11%
- Monte Rosa Therapeutics Inc. GLUE-311,801 shares · -46%
- Relay Therapeutics Inc. RLAY-154,144 shares · -10%
- Ethos Technologies Inc. LIFE-147,552 shares · -4%
Sold out of 1
- Tenaya Therapeutics Inc. TNYA$631,836 last quarter
What it holds
| Company | Shares | Value | Of its book | Change in shares |
|---|---|---|---|---|
| Space Exploration Techn Corp. Class A Com STK SPCX | 551,189,500 | $94.18 billion | 95.05% | new |
| Planet Labs PBC PL | 35,248,893 | $1.17 billion | 1.18% | no change |
| Ast Spacemobile Inc. ASTS | 8,943,486 | $794.7 million | 0.80% | no change |
| CME Group Inc. CME | 3,484,020 | $769.4 million | 0.78% | no change |
| Arm Holdings plc ARM | 1,960,784 | $695.2 million | 0.70% | no change |
| Revolution Medicines, Inc. RVMD | 2,946,619 | $551.8 million | 0.56% | -345,906 |
| Freshworks Inc. FRSH | 16,206,643 | $164.0 million | 0.17% | no change |
| Parabilis Medicines Inc. Com PBLS | 4,919,498 | $134.6 million | 0.14% | new |
| Tempus Ai Inc. TEM | 1,551,102 | $89.9 million | 0.09% | no change |
| Gitlab Inc. GTLB | 2,724,712 | $83.2 million | 0.08% | no change |
| UiPath, Inc. PATH | 7,034,337 | $76.5 million | 0.08% | no change |
| Ethos Technologies Inc. LIFE | 3,622,604 | $65.7 million | 0.07% | -147,552 |
| Prime Medicine Inc. PRME | 16,562,498 | $61.1 million | 0.06% | no change |
| Fervo Energy Co. Class A Com FRVO | 1,760,732 | $51.5 million | 0.05% | new |
| Paypay Corp. PAYP | 3,125,000 | $44.8 million | 0.05% | no change |
| Maze Therapeatics MAZE | 1,388,583 | $41.4 million | 0.04% | no change |
| Relay Therapeutics Inc. RLAY | 1,410,029 | $26.4 million | 0.03% | -154,144 |
| Bridgebio Oncology Therapeutics Ord BBOT | 2,823,126 | $21.5 million | 0.02% | no change |
| Oscar Health Inc. Class A OSCR | 481,988 | $13.7 million | 0.01% | no change |
| Beam Therapeutics Inc. BEAM | 321,604 | $11.0 million | 0.01% | no change |
| Vera Therapeutics Inc. VERA | 241,264 | $10.4 million | 0.01% | no change |
| Sana Biotechnology Inc. SANA | 2,812,500 | $9.8 million | 0.01% | no change |
| Monte Rosa Therapeutics Inc. GLUE | 372,474 | $9.0 million | 0.01% | -311,801 |
| Lyell Immunopharma Inc. LYEL | 293,256 | $4.1 million | 0.00% | no change |
| Figma Inc. FIG | 215,582 | $3.9 million | 0.00% | no change |
| Spero Therapeutics Inc SPRO | 889,979 | $2.0 million | 0.00% | no change |
| Hyperfine Inc. HYPR | 898,720 | $1.2 million | 0.00% | no change |
| Autolus Therapeutics PLC AUTL | 698,262 | $1.1 million | 0.00% | no change |
Every US-listed position in the fund's 13F for the quarter ended 30 June 2026, by the value it reported.